Insights

Innovative Ingredient Platform Debut's launch of the AI-based ingredient discovery platform BeautyORB demonstrates a commitment to rapid product innovation, providing opportunities to offer complementary technologies or consulting services in AI-driven formulation development to support their goal of delivering new ingredients faster.

Sustainable Biotechnology Focus With a specialization in inherently sustainable, clinically-proven ingredients, Debut presents a strong potential for partnerships with eco-conscious suppliers or sustainable ingredient providers interested in entering or expanding within the beauty industry.

Manufacturing Expansion Debut's substantial investment of up to $100 million to establish domestic production facilities signals upcoming opportunities to collaborate on manufacturing solutions, raw material supply chain optimization, or equipment provisioning for their advanced biomanufacturing needs.

Leadership & Growth Recent executive appointment of Derek Wanner as CCO indicates a focus on expanding commercial reach, creating openings for sales teams to introduce innovative ingredient solutions, formulation services, or strategic partnerships tailored for the evolving beauty biotech market.

Funding & Industry Position With a revenue range of $50 million to $100 million and recent investments, Debut is positioned for accelerated growth, offering opportunities for technology vendors, service providers, or strategic partners to support their scaling efforts in biotech innovation and product commercialization.

Debut Tech Stack

Debut uses 8 technology products and services including git, Shopify, OWL Carousel, and more. Explore Debut's tech stack below.

  • git
    Development
  • Shopify
    E-commerce
  • OWL Carousel
    Javascript Libraries
  • TensorFlow
    Machine Learning
  • Google Maps
    Maps
  • Webflow
    Page Builders
  • Lua
    Programming Languages
  • Yoast SEO
    Search Engines

Media & News

Debut's Email Address Formats

Debut uses at least 1 format(s):
Debut Email FormatsExamplePercentage
First@debutbiotech.comJohn@debutbiotech.com
67%
FLast@debutbiotech.comJDoe@debutbiotech.com
29%
Last@debutbiotech.comDoe@debutbiotech.com
3%
First.Last@debutbiotech.comJohn.Doe@debutbiotech.com
1%

Frequently Asked Questions

Where is Debut's headquarters located?

Minus sign iconPlus sign icon
Debut's main headquarters is located at 11545 Sorrento Valley Road Suite 310 San Diego, California 92121 United States. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is Debut's stock symbol?

Minus sign iconPlus sign icon
Debut is a publicly traded company; the company's stock symbol is DBTB.

What is Debut's official website and social media links?

Minus sign iconPlus sign icon
Debut's official website is debutbiotech.com and has social profiles on LinkedInCrunchbase.

What is Debut's SIC code NAICS code?

Minus sign iconPlus sign icon
Debut's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Debut have currently?

Minus sign iconPlus sign icon
As of March 2026, Debut has approximately 93 employees across 6 continents, including North AmericaEuropeAsia. Key team members include Ceo: D. B.Chief Commercial Officer: D. W.Head Of Marketing & Communications: L. Z.. Explore Debut's employee directory with LeadIQ.

What industry does Debut belong to?

Minus sign iconPlus sign icon
Debut operates in the Biotechnology Research industry.

What technology does Debut use?

Minus sign iconPlus sign icon
Debut's tech stack includes gitShopifyOWL CarouselTensorFlowGoogle MapsWebflowLuaYoast SEO.

What is Debut's email format?

Minus sign iconPlus sign icon
Debut's email format typically follows the pattern of First@debutbiotech.com. Find more Debut email formats with LeadIQ.

How much funding has Debut raised to date?

Minus sign iconPlus sign icon
As of March 2026, Debut has raised $20M in funding. The last funding round occurred on Aug 26, 2025 for $20M.

When was Debut founded?

Minus sign iconPlus sign icon
Debut was founded in 2019.

Debut

Biotechnology ResearchCalifornia, United States51-200 Employees

Debut is building the future of beauty with cutting-edge AI and biotechnology, creating high-performing, innovative ingredients and formulations that propel the industry forward. The company specializes in scientifically-discovered, clinically-proven and inherently sustainable ingredients that provide maximum efficacy. Named one of the TIME100 Most Innovative Companies 2025, Debut is redefining the beauty industry’s standards, centering on performance, potency and purity.

Section iconCompany Overview

Headquarters
11545 Sorrento Valley Road Suite 310 San Diego, California 92121 United States
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
DBTB
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
51-200

Section iconFunding & Financials

  • $20M

    Debut has raised a total of $20M of funding over 5 rounds. Their latest funding round was raised on Aug 26, 2025 in the amount of $20M.

  • $50M$100M

    Debut's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $20M

    Debut has raised a total of $20M of funding over 5 rounds. Their latest funding round was raised on Aug 26, 2025 in the amount of $20M.

  • $50M$100M

    Debut's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.